Micro RNA (miRNA) is a recently discovered class of transcription regulators. Its role in normal and malignant transformation has been extensively investigated. It is emerging that miRNA expression profiling may be a useful tool for diagnostic and prognostic purposes; however, only a limited number of studies have shown direct involvement of miRNA genes in malignant transformation. There are examples of the role of miRNA in the pathogenesis of B-cell lymphoid malignancies: expression of miR-155, miR-221 and miR-21 can distinguish between the activated B-cell phenotype and germinal center phenotype of diffuse large B-cell lymphoma; the miR-15a/miR-16-1 cluster, located on 13q14, is deleted in chronic lymphocytic leukemia (CLL). 1, 2 In myeloid disorders, a recurrent translocation, t(2;11)(p21;q24), has been shown to activate the miR-125b-1 on chromosome 11, which potentially defines a specific disease subtype. 3 A second locus containing miR-125b-2 is located on 21q21; chromosome 21 is frequently duplicated or rearranged in human hematological malignancies.
In B-cell lymphoid malignancies, chromosomal translocations affecting the immunoglobulin heavy chain locus (IGH@) are known to result in the transcriptional activation of a partner gene and to represent an important step in cellular transformation. Recently, a number of novel chromosomal breakpoints have uncovered previously unknown B-cell oncogenes. We now report the transcriptional activation of miR-125b-1 in the recurrent translocation, t(11;14)(q24;q32), involving IGH@ in B-cell precursor acute lymphoblastic leukemia (BCP-ALL), thereby extending the involvement of miR-125b-1 to lymphoid precursor transformation.
Two adult BCP-ALL patients with t(11;14)(q24;q32) were identified from the Groupe Francophone de Cytogénétique Hématologique (GFCH) (P1) and the Leukaemia Research UK Cancer Cytogenetics Group Karyotype Database in Acute Leukaemia (P2). The 28 BCP-ALL patients without t(11;14) were collected by the Service d'Hématologie Biologique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France and the Laboratoire de Biochimie Génétique, Hô pital Robert Debré, Paris, France. Samples were obtained with informed consent in accordance with the Declaration of Helsinki.
Conventional cytogenetic analysis was performed on diagnostic bone marrow samples using standard procedures. Fluorescence in situ hybridization (FISH) was carried out on the same diagnostic samples. The involvement of IGH@ was confirmed using the commercial LSI IGH dual-color break-apart rearrangement probe (Abbott Diagnostics, Rungis, France). A break-apart probe was designed to identify the involvement of miR-125b-1 in the translocation using bacterial artificial chromosome (BAC) clones RP11-164B14 and RP11-419A21 (Supplementary Figure 1) . The region of miR-125b-2 on 21q21 was analyzed with BAC clones RP11-10E12, RP11-165H8 and RP11-1051B20. Long-distance inverse PCR (LDI-PCR) from IGHJ was performed as previously described. Sequences were analyzed locally or at http://genome.ucsc.edu/ (human genome build hg18). Total RNA was extracted using standard methods. Reverse transcriptase-PCR (RT-PCR) was performed for each microRNA using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Courtaboeuf, France) according to the manufacturer's protocol. Quantitative real-time PCR (RQ-PCR) was performed on ABI7000 (Applied Biosystems) using TaqMan microRNA and TaqMan Gene Expression Assays (Applied Biosystems): hsa-miR-125b, hsa-miR-100, hsa-let-7a, RNU6B, Hs01034249_m1 (TP53), Hs01050896_m1 (MCL1) and Hs00940249_m1 (BAK1). Each sample was tested in duplicate in two independent experiments. The DCt method was used to quantify relative miRNA and mRNA expression levels using the endogenous reference RNA RNU6B and gene ABL, respectively.
Two BCP-ALL patients were identified with the chromosomal translocation, t(11;14)(q24;q32) (see Supplementary Table 1 for clinical details). Involvement of IGH@ at 14q32 was confirmed using FISH. The translocation breakpoint was cloned by LDI-PCR in both patients, located 10 559-bp apart within chromosomal band 11q24 (Figure 1a ). Both breakpoints bore the hallmark of VDJ activity: breakage close to a JH segment, presence of non-templated nucleotides and heptamer recognition signal close to the breakpoints on chromosome 11 (Figure 1b) . The involvement of 11q24 was confirmed using PCR and FISH analysis of metaphase chromosomes (Supplementary Figure 1) .
Within 11q24, a transcription unit, BLID, was identified to be highly expressed in patient P2 (data not shown). This transcription unit has been previously described to code for a proapoptotic BH3 protein. The open reading frame and the BH3 homology, however, appeared to be poorly conserved across species (Supplementary Figure 2) , arguing against a foreseeable role for this protein in cellular transformation.
Three miRNAs (miR-125b-1, let-7a-2 and miR-100) were located within the vicinity of the same breakpoint and, as a result of the translocation, all three relocated in cis to the immunoglobulin enhancer. RQ-PCR was used to compare their levels of transcription in patients with and without the t(11;14) (n ¼ 8, see Supplementary Table 2 ). Transcription of miR-100 was not detectable in most of the patients (Figure 2a ). However transcription of let-7a and of miR-125b was not uniform; let-7a showed an overall higher level in samples without the translocation, whereas the level of miR-125b was significantly higher in those samples with t(11;14) (P ¼ 0.03). Thus, these results suggest that miR-125b-1 is the crucial transcript activated by the t(11;14). It was interesting that one patient (C1) lacking t(11;14) expressed miR-125b at levels comparable to one of the patients with the translocation. This patient had the translocation, t(9;22)(q34;q11), with no evidence of structural or numerical abnormalities of 11q24 and 21q21 by cytogenetics or FISH (data not shown and Supplementary Table 2) .
To extend these observations, the transcription level of miR-125b was analyzed in another 20 BCP-ALL samples (see Supplementary Table 2 for details). This did not lead to the identification of additional samples expressing miR-125b. These results are summarized in Figure 2b .
To investigate the consequence of upregulation of miR-125b, the expression level of three putative miR-125b target mRNAs measured by quantitative RT-PCR were compared between t(11;14)-positive and negative samples. It has recently been suggested that TP53 is negatively regulated by miR-125b, 4 whereas MCL1 and BAK1 have been predicted by bioinformatics to be targets of miR-125b. None of these genes were shown to be underexpressed in the samples with t(11;14), compared with the control group (data not shown).
In this study we describe two BCP-ALL patients with the recurrent IGH@ translocation, t(11;14)(q24;q32), resulting in deregulation of miR-125b-1. Rearrangements of miR-125b-1 have been previously described in B-cell leukemia: an insertion of miR-125b-1 sequence into the IGH@ locus was observed in a patient with BCP-ALL, 5 and a translocation, t(11;14)(q24-32;q32), similar to those presented in this study, was recently described in a 2-year-old girl with B-ALL. 6 In these two cases, quantification of miR-125b-1 expression was not reported.
Two loci, miR-125b-1 and miR-125b-2, located on chromosomes 11 and 21, respectively, contain related sequences that would be similarly detected as a miR-125b transcript by RQ-PCR. Gefen et al. 7 reported increased expression of miR-125b in ETV6-RUNX1-positive BCP-ALL that peaked at approximately twice the normalization transcript. Using a different normalization transcript, ETV6-RUNX1-positive BCP-ALL did not show high levels of miR-125b expression in our study. However, in the three miR-125b-positive samples, the level of miR-125b expression reached at least 20 times the control transcript, far above the level of the ETV6-RUNX1 samples. Of interest was that patient P1 showed an additional copy of chromosome 21 in a proportion of cells, indicating that miR-125b overexpression cooperates with trisomy 21 in lymphoid precursor transformation (Supplementary Table 1) .
miR-125b promotes cellular proliferation and/or survival in various models. 7, 8 There were no mRNA level changes of candidate genes found among our patients; thus, the role of miR-125b overexpression remains to be determined in B-lymphoid precursor transformation. Letters to the Editor
